Crossmark

Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Türkiye

Crossref DOI link: https://doi.org/10.1007/s10096-024-04896-7

Published Online: 2024-07-12

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Buyukyanbolu, Ecem

Genc, Leyla

Cyr, Elizabeth A.

Karakus, Mehmet

Comert, Fusun

Otlu, Baris

Aktas, Elif

Nicolau, David P.
License Information

Text and Data Mining valid from 2024-07-12

Version of Record valid from 2024-07-12
More Information

Article History

Received: 18 April 2024

Accepted: 2 July 2024

First Online: 12 July 2024

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below